Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities

Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities

10.1007/s00520-011-1197-6

Saved in:
Bibliographic Details
Main Authors: Lacouture, M.E., Anadkat, M.J., Bensadoun, R.-J., Bryce, J., Chan, A., Epstein, J.B., Eaby-Sandy, B., Murphy, B.A.
Other Authors: PHARMACY
Format: Review
Published: 2014
Subjects:
EGFR inhibitors
Mucositis
Paronychia
Pruritus
Radiation dermatitis
Rash
Recommendations
Xerosis
Online Access:http://scholarbank.nus.edu.sg/handle/10635/106626
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-106626
record_format dspace
spelling sg-nus-scholar.10635-1066262023-10-30T20:37:37Z Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities Lacouture, M.E. Anadkat, M.J. Bensadoun, R.-J. Bryce, J. Chan, A. Epstein, J.B. Eaby-Sandy, B. Murphy, B.A. PHARMACY EGFR inhibitors Mucositis Paronychia Pruritus Radiation dermatitis Rash Recommendations Xerosis 10.1007/s00520-011-1197-6 Supportive Care in Cancer 19 8 1079-1095 SCCAE 2014-10-29T02:02:50Z 2014-10-29T02:02:50Z 2011-08 Review Lacouture, M.E., Anadkat, M.J., Bensadoun, R.-J., Bryce, J., Chan, A., Epstein, J.B., Eaby-Sandy, B., Murphy, B.A. (2011-08). Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities. Supportive Care in Cancer 19 (8) : 1079-1095. ScholarBank@NUS Repository. https://doi.org/10.1007/s00520-011-1197-6 09414355 http://scholarbank.nus.edu.sg/handle/10635/106626 000292306700003 Scopus
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic EGFR inhibitors
Mucositis
Paronychia
Pruritus
Radiation dermatitis
Rash
Recommendations
Xerosis
spellingShingle EGFR inhibitors
Mucositis
Paronychia
Pruritus
Radiation dermatitis
Rash
Recommendations
Xerosis
Lacouture, M.E.
Anadkat, M.J.
Bensadoun, R.-J.
Bryce, J.
Chan, A.
Epstein, J.B.
Eaby-Sandy, B.
Murphy, B.A.
Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities
description 10.1007/s00520-011-1197-6
author2 PHARMACY
author_facet PHARMACY
Lacouture, M.E.
Anadkat, M.J.
Bensadoun, R.-J.
Bryce, J.
Chan, A.
Epstein, J.B.
Eaby-Sandy, B.
Murphy, B.A.
format Review
author Lacouture, M.E.
Anadkat, M.J.
Bensadoun, R.-J.
Bryce, J.
Chan, A.
Epstein, J.B.
Eaby-Sandy, B.
Murphy, B.A.
author_sort Lacouture, M.E.
title Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities
title_short Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities
title_full Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities
title_fullStr Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities
title_full_unstemmed Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities
title_sort clinical practice guidelines for the prevention and treatment of egfr inhibitor-associated dermatologic toxicities
publishDate 2014
url http://scholarbank.nus.edu.sg/handle/10635/106626
_version_ 1781788277751152640

Similar Items